Antares Pharma, Inc. EBITDA 2010-2022 | ATRS
Antares Pharma, Inc. ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Antares Pharma, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $70 |
| 2020 | $16 |
| 2019 | $4 |
| 2018 | $-1 |
| 2017 | $-13 |
| 2016 | $-22 |
| 2015 | $-19 |
| 2014 | $-34 |
| 2013 | $-20 |
| 2012 | $-11 |
| 2011 | $-4 |
| 2010 | $-6 |
| 2009 | $-9 |
| Antares Pharma, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-03-31 | $-2 |
| 2021-12-31 | $47 |
| 2021-09-30 | $9 |
| 2021-06-30 | $8 |
| 2021-03-31 | $6 |
| 2020-12-31 | $7 |
| 2020-09-30 | $6 |
| 2020-06-30 | $4 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $6 |
| 2019-09-30 | $3 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $8 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-5 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-4 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $-6 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $-7 |
| 2015-12-31 | $-6 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-6 |
| 2014-12-31 | $-10 |
| 2014-09-30 | $-7 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-5 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-3 |
| 2012-03-31 | $-0 |
| 2011-12-31 | $-0 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $-2 |
| 2010-06-30 | $-2 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-2 |
| 2009-06-30 | $-2 |
| 2009-03-31 | $-2 |
